Skip to content

Nasdaq · CIK 0000096536

TAYD TAYLOR DEVICES, INC.

Insider trading from SEC Form 4. Last filing 8 d ago. Close $58.92 on Oct 9, 2026, +43% from the 52-week low and -35% from the high.

In brief

TAYLOR DEVICES, INC. (TAYD) has 21 SEC Form 4 filings on file from 6 insiders, the latest filed on Oct 5, 2026. No insider bought or sold on the open market in the last 90 days; rows filed in that time are grants, exercises, tax withholding and other transactions that carry no view on the price.

4 open-market trades have been scored at TAYD. The newest: Robert Michael Carey (director) sold $284k of stock on Apr 28, 2026, filed Apr 30, 2026, scored 39 (weak). The largest of the 4 shown: Fritz Eric Armenat (director) sold $311k on Jan 22, 2026, scored 49 (moderate).

1 Form 144 notice of planned sales is on file, the latest filed Apr 28, 2026.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
6
with a Form 4 at this company

Price and insider trades, last year

TAYDOct 9, 2026 · close 58.92

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at TAYLOR DEVICES, INC., scored.

ScoreInsiderValueHoldingsPrice contextFiled
39WeakRobert Michael Carey
director
sell
$284k
5,000 shares
-39%+83% from low-37% from high
49ModerateFritz Eric Armenat
director
sell
$311k
4,328 shares
-100%+137% from low-4% from high
49ModerateFritz Eric Armenat
director
sell
$302k
4,120 shares
-100%+143% from low0% from high
33WeakTimothy John Sopko
Chief Executive Officer
buy
$30k
1,000 shares
+11%-

Planned sales

Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales

FiledSellerSharesValueSale datePast 3 months
Apr 28, 2026 CAREY ROBERT MICHAEL
Director
5,000
0.16% of outstanding
$286kApr 28, 2026none

Transactions

Every row filed, 40 in all.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 2, 2026John Burgess
director
MOption exercise
Common Stock
+5,000$13.80$69k48,4268 d ago
Oct 2, 2026John Burgess
director
MOption exercise
Stock Option (Right to Buy)derivative
-5,000$0.00$008 d ago
Apr 28, 2026Robert Michael Carey
director
SOpen-market sale
Common Stock
-3,445$57.27$197k9,276Apr 30, 2026
Apr 28, 2026Robert Michael Carey
director
SOpen-market sale
Common Stock
-1,555$55.52$86k7,721Apr 30, 2026
Apr 18, 2026Fritz Eric Armenat
director
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 20, 2026
Apr 18, 2026John Burgess
director
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 20, 2026
Apr 18, 2026Robert Michael Carey
director
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 20, 2026
Apr 18, 2026Paul Murray Heary
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 20, 2026
Apr 18, 2026Timothy John Sopko
Chief Executive Officer
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 20, 2026
Apr 13, 2026John Burgess
director
MOption exercise
Common Stock
+5,000$16.40$82k45,000Apr 15, 2026
Apr 13, 2026John Burgess
director
FTax withholding
Common Stock
-1,574$52.11$82k43,426Apr 15, 2026
Apr 13, 2026John Burgess
director
MOption exercise
Stock Option (Right to Buy)derivative
-5,000$0.00$00Apr 15, 2026
Jan 22, 2026Fritz Eric Armenat
director
SOpen-market sale
Common Stock
-2,800$71.77$201k1,528Jan 26, 2026
Jan 23, 2026Fritz Eric Armenat
director
SOpen-market sale
Common Stock
-528$72.10$38k1,000Jan 26, 2026
Jan 23, 2026Fritz Eric Armenat
director
SOpen-market sale
Common Stock
-300$71.19$21k700Jan 26, 2026
Jan 23, 2026Fritz Eric Armenat
director
SOpen-market sale
Common Stock
-700$72.85$51k0Jan 26, 2026
Jan 21, 2026Fritz Eric Armenat
director
MOption exercise
Common Stock
+5,000$9.85$49k5,000Jan 23, 2026
Jan 21, 2026Fritz Eric Armenat
director
FTax withholding
Common Stock
-672$73.28$49k4,328Jan 23, 2026
Jan 21, 2026Fritz Eric Armenat
director
MOption exercise
Stock Option (Right to Buy)derivative
-5,000$0.00$00Jan 23, 2026
Jan 14, 2026Fritz Eric Armenat
director
SOpen-market sale
Common Stock
-3,820$73.21$280k300Jan 16, 2026
Jan 14, 2026Fritz Eric Armenat
director
SOpen-market sale
Common Stock
-300$74.00$22k0Jan 16, 2026
Jan 9, 2026Fritz Eric Armenat
director
MOption exercise
Common Stock
+5,000$11.98$60k5,000Jan 13, 2026
Jan 9, 2026Fritz Eric Armenat
director
FTax withholding
Common Stock
-880$68.06$60k4,120Jan 13, 2026
Jan 9, 2026Fritz Eric Armenat
director
MOption exercise
Stock Option (Right to Buy)derivative
-5,000$0.00$00Jan 13, 2026
Apr 23, 2025Timothy John Sopko
Chief Executive Officer
POpen-market purchase
Common Stock
+699$30.02$21k9,699Apr 24, 2025
Apr 23, 2025Timothy John Sopko
Chief Executive Officer
POpen-market purchase
Common Stock
+11$29.97$3309,710Apr 24, 2025
Apr 23, 2025Timothy John Sopko
Chief Executive Officer
POpen-market purchase
Common Stock
+290$30.07$8,72010,000Apr 24, 2025
Apr 18, 2025Paul Murray Heary
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 22, 2025
Apr 18, 2025Timothy John Sopko
Chief Executive Officer
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 22, 2025
Apr 18, 2025Alan Raymond Klembczyk
President
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 22, 2025
Apr 18, 2025Robert Michael Carey
director
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 22, 2025
Apr 18, 2025John Burgess
director
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 22, 2025
Apr 18, 2025Fritz Eric Armenat
director
AGrant or award
Stock Option (Right to Buy)derivative
-7,000$0.00$07,000Apr 22, 2025
Apr 14, 2025John Burgess
director
MOption exercise
Common Stock
+5,000$12.20$61k40,000Apr 16, 2025
Apr 14, 2025John Burgess
director
MOption exercise
Stock Option (Right to Buy)derivative
-5,000$12.20$61k0Apr 16, 2025
Oct 28, 2024Robert Michael Carey
director
MOption exercise
Common Stock
+5,000$11.95$60k10,000Oct 29, 2024
Oct 28, 2024Robert Michael Carey
director
MOption exercise
Common Stock
+5,000$9.53$48k15,000Oct 29, 2024
Oct 28, 2024Robert Michael Carey
director
FTax withholding
Common Stock
-2,279$47.12$107k12,721Oct 29, 2024
Oct 28, 2024Robert Michael Carey
director
MOption exercise
Stock Option (Right to Buy)derivative
-5,000$0.00$00Oct 29, 2024
Oct 28, 2024Robert Michael Carey
director
MOption exercise
Stock Option (Right to Buy)derivative
-5,000$0.00$00Oct 29, 2024

Insiders

Everyone who has filed a Form 4 here.

Questions about TAYD

Answered from the filings on this page, as of the latest one.

Are insiders buying TAYD?

No. In the last 90 days no insider at TAYLOR DEVICES, INC. bought or sold shares on the open market according to SEC Form 4 filings. The rows on file from that period are grants, exercises, tax withholding or other transactions, which carry no view on the price.

Who was the last insider to trade TAYD on the open market?

Robert Michael Carey (director) sold $284k of TAYD on Apr 28, 2026 and filed the Form 4 on Apr 30, 2026. InsiderTell scored 39 (weak).

How many insiders file Form 4 at TAYLOR DEVICES, INC.?

6 people have filed a Form 4 at TAYLOR DEVICES, INC., among them Fritz Eric Armenat (director), John Burgess (director), Robert Michael Carey (director). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

TAYD insider trading: TAYLOR DEVICES, INC. | InsiderTell